NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer
NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer
Recruiting · NCT06259929 · Registry updated 2025-02-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-02-18 | NCT06259929 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fondazione Oncotech | 2 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AOU Federico II | Naples | Italy | 1 |
| Fondazione Universitaria Policlinico Gemelli IRCCS | Roma | Italy | 1 |
| Humanitas Istituto Clinico Catanese | Catania | Italy | 1 |
| IRCCS Centro di Riferimento Oncologico (CRO) | Aviano | Italy | 1 |
| IRCCS Ospedale Policlinico San Martino | Genova | Italy | 4 |
| Istituto Nazionale Tumori "G. Pascale" | Naples | Italy | 1 |
| Istituto Oncologico Veneto IRCCS | Padova | Italy | 3 |
| Ospedale Fatebenefratelli - Isola Tiberina | Roma | Italy | 1 |